Pacific Biosciences Of California (PACB) Shares Outstanding (Diluted Average) (2020 - 2025)
Historic Shares Outstanding (Diluted Average) for Pacific Biosciences Of California (PACB) over the last 7 years, with Q3 2025 value amounting to $300.8 million.
- Pacific Biosciences Of California's Shares Outstanding (Diluted Average) rose 1023.36% to $300.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.8 million, marking a year-over-year increase of 1023.36%. This contributed to the annual value of $288.4 million for FY2024, which is 1369.6% up from last year.
- Pacific Biosciences Of California's Shares Outstanding (Diluted Average) amounted to $300.8 million in Q3 2025, which was up 1023.36% from $300.2 million recorded in Q2 2025.
- In the past 5 years, Pacific Biosciences Of California's Shares Outstanding (Diluted Average) registered a high of $300.8 million during Q3 2025, and its lowest value of $198.6 million during Q2 2021.
- For the 5-year period, Pacific Biosciences Of California's Shares Outstanding (Diluted Average) averaged around $250.9 million, with its median value being $251.8 million (2023).
- As far as peak fluctuations go, Pacific Biosciences Of California's Shares Outstanding (Diluted Average) skyrocketed by 2892.51% in 2021, and later skyrocketed by 464.66% in 2022.
- Over the past 5 years, Pacific Biosciences Of California's Shares Outstanding (Diluted Average) (Quarter) stood at $204.1 million in 2021, then grew by 10.0% to $224.6 million in 2022, then increased by 12.95% to $253.6 million in 2023, then grew by 13.7% to $288.4 million in 2024, then increased by 4.33% to $300.8 million in 2025.
- Its Shares Outstanding (Diluted Average) was $300.8 million in Q3 2025, compared to $300.2 million in Q2 2025 and $296.9 million in Q1 2025.